Axa S.A. Bicycle Therapeutics PLC Transaction History

Axa S.A.

$32.2 Billion
Q4 2024

A detailed history of Axa S.A. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Axa S.A. holds 553,959 shares of BCYC stock, worth $3.92 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

553,959

Previous 554,399 0.08%

Holding current value

$3.92 Million

Previous $12.6 Million 38.32%

% of portfolio

0.02%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.81 - $27.5 $6,076 - $12,100	-440 Reduced 0.08%	553,959 $7.76 Million
Q3 2024 Nov 14, 2024	BUY	$19.58 - $27.24 $1,546 - $2,151	79 Added 0.01%	554,399 $12.6 Million
Q2 2024 Feb 25, 2025	BUY	$20.02 - $24.69 $7,227 - $8,913	361 Added 0.07%	554,320 $11.2 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $24.69 $3,143 - $3,876	157 Added 0.03%	554,320 $11.2 Million
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $1,289 - $2,009	77 Added 0.01%	554,163 $13.8 Million
Q4 2023 Jul 16, 2024	SELL	$13.29 - $22.2 $1,023 - $1,709	-77 Reduced 0.01%	554,086 $10 Million
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $278,837 - $465,778	-20,981 Reduced 3.65%	554,086 $10 Million
Q3 2023 Nov 14, 2023	BUY	$19.9 - $26.25 $426,556 - $562,668	21,435 Added 3.87%	575,067 $11.6 Million
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $1.77 Million - $2.68 Million	93,507 Added 20.32%	553,632 $14.1 Million
Q1 2023 May 15, 2023	BUY	$20.02 - $31.37 $1.59 Million - $2.5 Million	79,570 Added 20.91%	460,125 $9.79 Million
Q4 2022 Feb 14, 2023	SELL	$20.37 - $32.9 $612,831 - $989,796	-30,085 Reduced 7.33%	380,555 $11.3 Million
Q3 2022 Feb 14, 2023	SELL	$17.49 - $28.44 $916,248 - $1.49 Million	-52,387 Reduced 11.31%	410,640 $9.55 Million
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $916,248 - $1.49 Million	-52,387 Reduced 11.31%	410,640 $9.55 Million
Q2 2022 Feb 14, 2023	BUY	$12.95 - $46.99 $4.12 Million - $14.9 Million	317,773 Added 218.77%	463,027 $7.77 Million
Q2 2022 Aug 15, 2022	BUY	$12.95 - $46.99 $4.12 Million - $14.9 Million	317,773 Added 218.77%	463,027 $7.77 Million
Q1 2022 Feb 14, 2023	SELL	$40.12 - $59.5 $10.6 Million - $15.8 Million	-265,386 Reduced 64.63%	145,254 $6.37 Million
Q1 2022 May 13, 2022	BUY	$40.12 - $59.5 $80 - $119	2 Added 0.0%	145,254 $6.37 Million
Q4 2021 Feb 14, 2022	SELL	$41.7 - $61.14 $2.23 Million - $3.27 Million	-53,421 Reduced 26.89%	145,252 $8.84 Million
Q3 2021 Nov 15, 2021	BUY	$27.95 - $44.24 $32,505 - $51,451	1,163 Added 0.59%	198,673 $8.26 Million
Q2 2021 Aug 13, 2021	SELL	$27.0 - $32.28 $7,803 - $9,328	-289 Reduced 0.15%	197,510 $6 Million
Q1 2021 May 14, 2021	BUY	$19.12 - $30.25 $1.01 Million - $1.6 Million	52,802 Added 36.42%	197,799 $5.91 Million
Q4 2020 Feb 12, 2021	BUY	$17.95 - $21.36 $2.6 Million - $3.1 Million	144,997 New	144,997 $2.6 Million

Others Institutions Holding BCYC

# of Institutions

103

Shares Held

42.9M

Call Options Held

12.1K

Put Options Held

17.4K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $210M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account